Patricia Ghory
Allergy & Immunology · Cincinnati, OHNPI 1649298829
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 208 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,406 and has fallen 83.2% since, to $237 in 2024.
Across 208 payments — averaging $21.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$992
- GSK$572
- Sanofi$544
- Regeneron Healthcare Solutions, Inc.$444
- Genentech USA, Inc.$431
- Covis Pharma GmbH$229
- plus $1K from 20 others
What the payments were for
- Consulting fees$331%
- Food & beverage$4,44399%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 37 | $992 |
| GSK | 44 | $572 |
| Sanofi | 22 | $544 |
| Regeneron Healthcare Solutions, Inc. | 13 | $444 |
| Genentech USA, Inc. | 14 | $431 |
| Covis Pharma GmbH | 12 | $229 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $150 |
| Pfizer | 8 | $143 |
| CSL Behring | 7 | $116 |
| Boehringer Ingelheim | 7 | $102 |
| Amgen(2 entities) | 5 | $94 |
| Octapharma USA, Inc. | 5 | $92 |
| Sanofi-aventis U.S. LLC | 1 | $86 |
| Kaleo, Inc. | 3 | $57 |
| ADMA Biomanufacturing LLC | 6 | $53 |
| Optinose US, Inc. | 4 | $52 |
| Novartis | 3 | $51 |
| Grifols USA, LLC | 2 | $48 |
| Alk-abello, Inc | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 3 | $38 |
| Bio Products Laboratory USA, Inc. | 2 | $35 |
| Blueprint Medicines Corporation | 1 | $27 |
| Jubilant Hollisterstier LLC | 1 | $24 |
| Incyte Corporation | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $17 |
| LEO Pharma Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,476 in reported general payments places this provider in the 60th percentile of 128 allergy & immunology providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 11 | $609 |
| Montelukast Sodium | 12 | $205 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Cincinnati
- Justin GreiweCincinnati$1M
- Jonathan BernsteinCincinnati$810K
- Gordon MyersCincinnati$346K
- David BernsteinCincinnati$93K
- Sheharyar DurraniCincinnati$87K
- Joshua BernsteinCincinnati$18K
- David TapkeCincinnati$17K
- Jeffrey RaubCincinnati$14K
- Juan AboniaCincinnati$12K
- John SeyerleCincinnati$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.